![](/wp-content/uploads/2023/06/Screenshot-2023-06-24-at-5.22.01-PM.png)
$599
ADA 2023 Key Press Releases (June 24)
On the second day of ADA 2023, ten cardiometabolic-related news items were observed from Lilly, Zealand, BI, Novo Nordisk, Biomea Fusion, Sciwind Biosciences, Medtronic, Vertex, and Esperion. Below, FENIX provides context and analysis for the announcements.